Cure - The Future of Putters, Here & Now!
Where it began
The story and meteoric rise of Cure putters began in the spring of 2013 when retired architect Steve Davis booked a lesson with PGA Professional Jeff Ryan at his home club course, Hammock Dunes. Steve noticed a huge mallet putter in Jeff’s bag and curiosity saw Steve rolling a few putts and Jeff explaining the advantages of the putter and it’s high MOI.
A conversation then ensued, the result of which saw the 2 men collaborating on designing and building a few putters. The goal was to create a putter that was built to take away all the possible variables that contribute to problems experienced by players when putting. The single goal was to build a putter that EVERY golfer would benefit from.
Jeff and Steve kicked things into gear and within a few weeks they had their very first prototype, the RX1. They adjusted the weight and lie-angle to suit, and began testing the putter, the results were astonishing. Incredible stability coupled with outstanding control, consistent line and a great sound. It was apparent that they had created something very special indeed.
They began showing the putter to friends and a few select professional golfers, the feedback was overwhelmingly positive. The pair then headed up to TPC and presented the putter to former PGA Tour Commissioner Deane Beman who immediately beamed and said, “that’s a lie adjustable, high MOI putter!” Deane excitedly rolled in putt after putt on the practice green and was so smitten he proclaimed that not only was the RX1 the most advanced putter he had ever seen, he wanted to be involved.
The creation of Cure Putters
Having such a huge endorsement quickly led to the formation of Cure Putters with Deane Beman joining the company as an equity partner. Having a man who not only had a tremendous career as a tour professional but also played a significant role in the growth and popularity of the sport in his 20 years as the PGA Tour Commissioner helped push the testing and development of the putters to a new level.
A diverse team was assembled and the first putters created, the RX1 & RX2 were launched at the 2014 PGA Merchandise show in Orlando, once again the response from players, pro’s and celebrities was phenomenal. Indeed the show spotlight listed Cure Putters as their number 1 new product.
In June of 2014, Jim Barfield, former Co-Founder of Rife Putters left the company he helped build to join Cure Team. New shaft and colour options were introduced and momentum really began to build with everyone from high handicappers to Tour players were seeing remarkable improvements in their putting.
Jim sadly passed away in December 2016, he was a key member of the Cure Putters team in his role as the Vice President of Professional Tour Operations. He worked primarily out on the Champions Tour but also helped with the strategic planning and the product road map for the company. He is sadly missed by the Cure family.
Throughout 2015, Cure continued to experience explosive growth, with nearly 600 domestic retail accounts and distribution in 6 countries. Cure Putters became the Fastest Growing Putter on the Champions Tour and has a growing number of LPGA players.
The 2017 line up includes 6 models, the RX range and the Cure Classic Series, a High MOI blade putter. Very traditional in style, just slightly oversized with large tungsten weight inserts in the heel and toe, creating the most aggressive weight ratio of any blade putter in history. The putters have been tested and reviewed all around the world and you will be hard pushed to find a review that isn’t glowing about the putters and what they can do for your game.